Abstract: A composition comprising a standardized amount of a schisandrin compound and methods for production thereof for use in reducing stress, increasing blood antioxidant level, reducing lipid peroxidation and/or improving symptoms of depression in subjects in need thereof.
Type:
Grant
Filed:
July 31, 2015
Date of Patent:
May 30, 2017
Assignee:
Rubikon Ltd.
Inventors:
Viktar Farber, Viatcheslav Smetanin, Alena Hukava, Andrei Mastykau